The Rundown Trump Targets Netflix Amid DOJ Probe; Slaps New 15% Tariffs
6 snips
Feb 23, 2026 News of new 15% tariffs and legal maneuvering shakes markets. DOJ scrutiny and bidding drama swirl around streaming and Hollywood deals. GLP-1 drug race heats up as trial results shift competitive positions. Domino’s value strategy drives fresher-than-expected retail results. Big biotech M&A and a quirky nugget about the tiny gold in Olympic medals round out the update.
AI Snips
Chapters
Transcript
Episode notes
Tariff Ruling Cleared But Uncertainty Remains
- The Supreme Court struck down many of Trump's IEPA tariffs but uncertainty persists because not all tariffs were removed.
- Zaid Admani explains 60% of tariffs were ruled illegal while 40% remain and the president responded by imposing 15% tariffs under the 1974 Trade Act for 150 days.
New 15% Tariffs Buy Time For Legal Cases
- President Trump imposed new 15% across-the-board tariffs using Section 122 of the 1974 Trade Act for an initial 150 days.
- The administration plans to use those 150 days to build Section 301 and Section 232 cases against individual countries.
Novo Nordisk Trial Loss Widens GLP-1 Gap
- Novo Nordisk's next-gen obesity shot Cagri Sema underperformed versus Eli Lilly's Zepbound in a head-to-head trial.
- Cagri Sema delivered 20.2% weight loss vs Zepbound's 23.6% at 84 weeks, sinking Novo shares over 10%.